Results 151 to 160 of about 162,405 (296)

A comparative real-world analysis of finerenone and steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease. [PDF]

Front Pharmacol
Vetrano D, Cianciolo G, Barbuto S, Ribichini D, Berti S, Mistretta A, Ginesi M, Millar PT, Grimaldi A, Vischini G, Poluzzi E, Pagotto U, La Manna G, Capelli I.   +13 more
europepmc   +1 more source

TRIM Expression and Its Association With Disease Activity in Systemic Lupus Erythematosus

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse manifestations, including rash, arthritis, and nephritis. Although autoantibodies are a key feature of SLE, their levels often poorly reflect disease severity, suggesting the involvement of additional contributing factors.
Ling‐Ying Lu, Ling‐Jung Yen, Hui‐Ling Hsia, Zi‐Xeng Weng, Chi‐Hsiang Chung, Paul Wei‐Che Hsu, Chih‐Wei Chiu, Wu‐Chien Chien, Tsung‐Hsien Chang   +8 more
wiley   +1 more source

Does baseline proteinuria affect the efficacy of obinutuzumab in patients with primary membranous nephropathy and minimal change disease? a single-center retrospective study. [PDF]

Front Pharmacol
Li X, Zhang Y, Ke B.
europepmc   +1 more source

Proteinuria in Diabetes

Journal of the Royal College of Physicians of London, 2000
Thomas, S, Viberti, G C
openaire   +2 more sources

Measurement of Proteinuria [PDF]

Nephron, 2008
R H, White, C M, Taylor, A, Green
openaire   +2 more sources

Determinants of Early Renal Function Recovery After TIPS in Patients With Portal Hypertension

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Renal dysfunction frequently occurs in patients with portal hypertension and is linked to unfavorable clinical outcomes. Transjugular intrahepatic portosystemic shunt (TIPS) has the potential to enhance renal perfusion through portal decompression; however, factors predicting early improvement in renal function remain insufficiently defined ...
Meng Jia, Yang Luo, Zhao‐Yang Tan, Xiao‐Ling Zhou, Xi‐You Zhang, Jing‐Ying Sun, Ye Du   +6 more
wiley   +1 more source

Association of finerenone with graded proteinuria improvement in type 2 diabetes with chronic kidney disease and proteinuria >1 g/d: a retrospective cohort study. [PDF]

Front Endocrinol (Lausanne)
Sun N, Song X, Hu N, Li J, Zhang F, Chang W.   +5 more
europepmc   +1 more source

Interleukin-6, Proteinuria, and Arterial Stiffness in Preeclampsia: Distinct Inflammatory, Renal, and Vascular Associations. [PDF]

Biomedicines
Petre I, Iurciuc M, Buleu F, Popa D, Marc L, Buleu T, Marin I, Dragomir R, Mladin NC, Mercioni MA, Petre I.   +10 more
europepmc   +1 more source

Rethinking Proteinuria During Vascular Endothelial Growth Factor-Axis Therapy: Toward a Biopsy-Informed Approach. [PDF]

Kidney Int Rep
Furuto Y, Gupta S.
europepmc   +1 more source

Toxicity Differences Between Microplastics and Nanoplastics in Organs: From Molecular Mechanisms to Potential Therapeutic Strategies

Med Research, EarlyView.
This review systematically compares the size‐dependent toxicity of microplastics and nanoplastics in the intestine, liver, kidney, lung, and brain. Particle size determines bioavailability, barrier penetration, and injury mechanisms. Because of their small size and high surface reactivity, NPs readily cross the intestinal epithelium and blood–brain ...
Yixian Cheng, Junjie Chen, Rui Fu, Jiawei Zhang, Jianguang Jia, Wei Wang, Zheng Zhang, Peng Zhang, Haosong Chen, Huake Cao, Gang Li, Weiwei Sheng, Ting Li, Bo Chen, Guodong Cao   +14 more
wiley   +1 more source